Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer survivorship and care, Cancer-related cognitive impairment studies, Brain Metastases and Treatment, and Patient-Provider Communication in Healthcare.
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
An Online Preoperative Screening Tool to Optimize Care for Patients Undergoing Cancer Surgery: A Mixed-Method Study Protocol
International Survey of Psychosocial Care for Cancer Survivors in Low-/Middle- and High-Income Countries: Current Practices, Barriers, and Facilitators to Care
Impact of Cognitive Rehabilitation on Cognitive and Functional Outcomes in Adult Cancer Survivors: A Systematic Review
Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients
Carer preparedness improved by providing a supportive educational intervention for carers of patients with high-grade glioma: RCT results
Caregiver fear of cancer recurrence: A systematic review and meta‐analysis of quantitative studies
Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer
Screening for cognitive symptoms among cancer patients during chemotherapy: Sensitivity and specificity of a single item self‐report cognitive change score
A randomised controlled trial evaluating two cognitive rehabilitation approaches for cancer survivors with perceived cognitive impairment
Supportive Care Interventions for People With Cancer Assisted by Digital Technology: Systematic Review
Scanxiety: a scoping review about scan-associated anxiety
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP
Living with and beyond metastatic non-small cell lung cancer: the survivorship experience for people treated with immunotherapy or targeted therapy
Acceptability and appropriateness of a clinical pathway for managing anxiety and depression in cancer patients: a mixed methods study of staff perspectives
Irregular Sleep/Wake Patterns Are Associated With Reduced Quality of Life in Post-treatment Cancer Patients: A Study Across Three Cancer Cohorts
A review of the barriers to using Patient‐Reported Outcomes (PROs) and Patient‐Reported Outcome Measures (PROMs) in routine cancer care
Health literacy, digital health literacy and the implementation of digital health technologies in cancer care: the need for a strategic approach
Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group
Using patient‐reported outcomes (PROs) and patient‐reported outcome measures (PROMs) in routine head and neck cancer care: What do health professionals perceive as barriers and facilitators?
Correlates of cognitive impairment in adult cancer survivors who have received chemotherapy and report cognitive problems
Clinical Oncology Society of Australia position statement on cancer survivorship care
Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial
Health concerns of cancer survivors after primary anti-cancer treatment
Content comparison of unmet needs self‐report measures used in patients with head and neck cancer: A systematic review
A survey of patient and caregiver experience with malignant pleural mesothelioma
Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment
Psychological support for patients with cancer: evidence review and suggestions for future directions
How long is too long? A scoping review of health system delays in lung cancer
Important differences and meaningful changes for the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog)